Our portfolio

Haermonics

Innovating post-surgery care, Haermonics develops a device to flush and clean the pericardial space, preventing blood-related complications after open-heart surgery. Their technology reduces the risk of blood clots and subsequent operations. The company is dedicated to improving surgical outcomes through advanced medical devices.

Industry: Cardiology, Medical Technology, Surgery

Want to get in contact about Haermonics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Enhancing microscopes with low-power super-resolution imaging solutions.
Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.
AI-driven oncology biomarker quantification for digital pathology.
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Enhancing microscopes with low-power super-resolution imaging solutions.
Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.
AI-driven oncology biomarker quantification for digital pathology.